Frequent Expression of bcl-2 Protein in Solitary Fibrous Tumors

Japanese Journal of Clinical Oncology

Volumn 28, Issue 2, 1998, Pages 86-91

  Hasegawa, Tadashi ^a   Matsuno, Yoshihiro ^a   Shimoda, Tadakazu ^a   Hirohashi, Setsuo ^a   Hirose, Takanori ^b   Sano, Toshiaki ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

bcl 2; CD34; Immunohistochemistry; Soft tissue tumor; Solitary fibrous tumor

Indexed keywords

CD34 ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOMA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR; RETROPERITONEAL TUMOR; SOFT TISSUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOMA; MALE; MIDDLE AGED; NEOPLASMS, FIBROUS TISSUE; PLEURAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROPERITONEAL NEOPLASMS; SOFT TISSUE NEOPLASMS;

EID: 0031990978     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.2.86     Document Type: Article

References (38)

1. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14,18) chromosome translocation. Science 1984:226:1097-9.
2. Korsmeyer SJ. bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992,80:879-86.
3. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990;137:225-32.
4. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ bcl-2 protein is topographically restricted in tissues characterized by a apoptotic cell death. Proc Natl Acad Sci USA 1991:88:6961-5.
5. Lu QL, Poulsom R, Wong L, Hanby AM. bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 1993;169:431-7.
6. Swanson PE, Humphrey PA, Dehner LP. Immunoreactivity for bcl-2 protein in peripheral neuroectodermal tumor Appl Immunohistochem 1993;1:182-7.
7. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa J. bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 1994;88:520-6.
8. Van den Oord JJ, Vandeghmste N, De Ley M, De Wolf-Peeters C. bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol 1994;145:294-300.
9. Pezzella F, Gatter K. What is the value of bcl-2 protein detection for histopathologists? Histopathology 1995;26:89-93.
10. Lu GL, Abel P, Foster CS, Lalani EN. bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 1996;27:102-10
11. Dada MA, Chetty R, Biddolph SC, Schneider JW, Gatter KC. The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma. Histopathology 1996;29.159-63.
12. Hirakawa N, Naka T, Yamamoto I, Fukuda T, Tsuneyoshi M. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum Pathol 1996;27:1060-5.
13. Chilosi M, Facchetti F, Dei Tos AP, Lestani M, Morassi ML, Martignoni G, et al. bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol 1997;181:362-7
14. Renshaw AA, Pinkus GS, Corson JM. CD34 and AE1/AE3: diagnostic discriminants in the distinction of solitary fibrous tumor of the pleura from sarcomatoid mesothehoma. Appl Immunohistochem 1994;2:94-102.
15. Van de Rijn M, Lombard CM, Rouse RV. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum and lung Am J Surg Pathol 1994;18:814-20.
16. Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor: consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol 1994;18:992-8
17. Flint A, Weiss SW. CD-34 and keratin expression distinguishes solitary fibrous tumor (fibrous mesothelioma) of pleura from desmoplastic mesothelioma. Hum Pathol 1995;26:428-31
18. Hanau CA, Miettinen M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol 1995;26:440-9.
19. Suster S, Nascimento AG, Miettinen M, Sickel JZ, Moran CA. Solitary fibrous tumors of soft tissue: a clinicopathological and immunohistochemical study of 12 cases. Am J Surg Pathol 1995;19:1257-66.
20. Fukunaga M, Ushigome S, Nomura K, Ishikawa E. Solitary fibrous tumor of the nasal cavity and orbit Pathol Int 1995;45:952-7.
21. Carneiro SS, Scheithauer BW, Nascimento AG, Hirose T, Davis DH. Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma: a clinicopathological and immunohistochemical study. Am J Clin Pathol 1996;106:217-24.
22. Hasegawa T, Hirose T, Seki K, Yang P, Sano T. Solitary fibrous tumor of the soft tissue: an immunohistochemical and ultrastructural study. Am J Clin Pathol 1996;106:325-31.
23. Fukunaga M, Naganuma H, Nikaido T, Harada T, Ushigome S Extrapleural solitary fibrous tumor: a report of seven cases. Mod Pathol 1997;10:443-50.
24. England DM, Hochholzer L, McCarthy MJ Localized benign and malignant fibrous tumors of the pleura: a clinicopathological review of 223 cases. Am J Surg Pathol 1989;13:640-58.
25. Goodlad JR, Fletcher COM. Solitary fibrous tumour arising at unusual sites: analysis of a series. Histopathology 1991;19:515-22.
26. Brooks JSJ Immunohistochemistry in the differential diagnosis of soft tissue tumors. In: Weiss SW, Brooks JSJ, editors. Soft Tissue Tumors. Baltimore: Williams & Wilkins, 1996;65-128.
27. Ramam P, Bradley NJ, Fletcher CDM. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections Histopathology 1990;17:237-42.
28. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 1991;96:25-31.
29. Cohen PR, Rapini RP, Farhood AI. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. J Cutan Pathol 1993;20:15-20.
30. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors and related lesions. Am J Surg Pathol 1993;17.1039-45.
31. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34 and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7.82-90.
32. Shirgi KE, Wick MR, Swanson PE. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors: adjuncts in the recognition of endothelial neoplasms. Am J Surg Pathol 1993,17:179-85.
33. Rizeq MN, van de Rijn M, Hendrickson MR, Rouse RV. A comparative immunohistochemical study of uterine smooth muscle neoplasms with emphasis on the epithelioid variant. Hum Pathol 1994;25:671-7.
34. Suster S, Fisher C. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors. Am J Surg Pathol 1997;21:195-200
35. Van de Rijn M, Rouse RV. CD34: a review. Appl Immunohistochem 1994;2:71-80.
36. Dal Cin P, Sciot R, Fletcher CDM, Hilliker C, De Wever I, Van Damme B, et al. Trisomy 21 in solitary fibrous tumor. Cancer Genet Cytogenet 1996;86:58-60.
37. Briselli M, Mark EJ, Dickersin GR. Solitary fibrous tumors of the pleura: eight new cases and review of 360 cases in the literature. Cancer 1981;47:2678-89.
38. Ibrahim NBN, Briggs JC, Corrin B. Double primary localized fibrous tumours of the pleura and retroperitoneum. Histopathology 1993;22:282-4.